Stem cell transplantation outcomes ‘improved with new drug regime’ – Medical News Today
|
Stem cell transplantation outcomes ‘improved with new drug regime’
Medical News Today New research suggests that outcomes for patients who have undergone stem cell transplants from unrelated or mismatched donors could be improved with the use of a drug called bortezomib, also known as velcade. This is according to a study presented at … |



